International Medical Development Group LLC is categorized under in Minneapolis, MN and active since 2011.
International Medical Development Group LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 423450 by the NAICS.
If you are seeking more information, feel free to contact Samuel M Dorfman at the company’s single location by writing to 5042 Yuma Lane North, Minneapolis, Minnesota MN 55446 or by phoning (612) 386-0298. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | International Medical Development Group LLC |
| Contact Person: | Samuel M Dorfman |
| Address: | 5042 Yuma Lane North, Minneapolis, Minnesota 55446 |
| Phone Number: | (612) 386-0298 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 5047 |
| NAICS Code: | 423450 |
| Share This Business: |
International Medical Development Group LLC was started in 2011 to provide professional under the SIC code 5047 and NAICS code 423450. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Samuel M Dorfman for inquiries that concern International Medical Development Group LLC by calling the company number (612) 386-0298, as your correspondence is most welcome. Additionally, the physical location of the single location of International Medical Development Group LLC can be found at the coordinates 45.045512,-93.484086 as well as the street address 5042 Yuma Lane North in Minneapolis, Minnesota 55446.
For its online presence, you may visit International Medical Development Group LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.